Status:
WITHDRAWN
The Effectiveness of Idazoxan in Treating TRD
Lead Sponsor:
Sheba Medical Center
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Assessing the effectiveness of Idazoxan as a treatment for depressive patients who did not respond to treatment with SSRI
Eligibility Criteria
Inclusion
- MDD patients
- Did not respond to at least one treatment of 4-6 weeks of SSRI in adequate dose
- In or out patients
Exclusion
- Psychotic symptoms
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00294944
Last Update
January 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chaim Sheba Medical Center
Ramat Gan, Israel, 52621